Monday, October 09, 2006

New River Receives Approval Letter

New River Pharmaceuticals Inc. (NRPH) received an approval letter from the FDA for the attention deficit and hyperactivity treatment it developed with Shire Plc. Shares of New River leaped $16.11 to close at $42.324.

0 Comments:

Post a Comment

<< Home